Recordati Industria Chimica e Farmaceutica Logo

Recordati Industria Chimica e Farmaceutica

REC | XMIL

Overview

Corporate Details

ISIN(s):
IT0003828271 (+4 more)
LEI:
815600FBF92FD3531704
Country:
Italy
Address:
VIA MATTEO CIVITALI, 1, 20148 MILANO
Sector:
Health Care
Industry:
Pharmaceuticals

Description

Recordati is a well-established international pharmaceutical group dedicated to the research, development, manufacturing and marketing of pharmaceuticals with more than 4,300 employees listed on the Italian Stock Exchange since 1984. Headquartered in Milan, Italy, Recordati has operations in Europe, Russia and the other C.I.S. countries, in Ukraine, Turkey, North Africa, the United States of America, Canada, Mexico, some South American countries, Japan and Australia. Recordati offers a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas including a specialized segment dedicated to treatments for rare diseases. An efficient field force of medical representatives and orphan drug representatives promotes its products in about 150 markets.

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-05 20:23
Regulatory News Service
Allegato 3F
Italian 30.4 KB
2025-08-05 20:07
Transaction in Own Shares
RECORDATI: Update on the execution of the share buy-back program
English 630.6 KB
2025-08-05 20:03
Transaction in Own Shares
RECORDATI: Aggiornamento sull’esecuzione del programma di acquisto di azioni pr…
English 605.2 KB
2025-08-04 20:03
Board/Management Change
RECORDATI: RESIGNATION OF A STANDING STATUTORY AUDITOR AND REPLACEMENT BY AN AL…
English 159.3 KB
2025-08-04 20:01
Board/Management Change
RECORDATI: DIMISSIONI DI UN SINDACO EFFETTIVO E SUBENTRO DI UN SINDACO SUPPLENTE
Italian 133.4 KB
2025-07-31 19:40
Regulatory News Service
RECORDATI: PUBLICATION OF THE MINUTES OF THE BOARD OF DIRECTORS’ MEETING HELD O…
English 233.4 KB
2025-07-31 19:38
Regulatory News Service
RECORDATI: PUBBLICAZIONE DEL VERBALE DEL CONSIGLIO DI AMMINISTRAZIONE DEL 29 LU…
Italian 200.9 KB
2025-07-31 19:32
Regulatory News Service
Verbale del Consiglio di Amministrazione del 29.07.2025 ai sensi dell’art. 72, …
Italian 428.4 KB
2025-07-31 16:34
Quarterly Report
RECORDATI: PUBLICATION OF THE INTERIM REPORT FIRST HALF (AS AT 30.06.2025)
English 162.9 KB
2025-07-31 16:32
Quarterly Report
RECORDATI: PUBBLICAZIONE DELLA RELAZIONE FINANZIARIA SEMESTRALE AL 30.06.2025
Italian 202.7 KB
2025-07-31 16:20
Interim Report
Interim report first half as at 30 June 2025 and related report of the auditing…
English 1.9 MB
2025-07-31 16:18
Interim Report
Relazione finanziaria semestrale al 30 giugno 2025 e relativa relazione della s…
Italian 1.4 MB
2025-07-30 20:12
Transaction in Own Shares
RECORDATI: Update on the execution of the share buy-back program
English 311.3 KB
2025-07-30 20:10
Transaction in Own Shares
RECORDATI: Aggiornamento sull’esecuzione del programma di acquisto di azioni pr…
Italian 285.7 KB
2025-07-30 15:30
Earnings Release
Presentazione “First Half 2025 Results”
English 864.9 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
ABIVAX Logo ABIVAX France ABVX
Addex Therapeutics Ltd Logo Addex Therapeutics Ltd Switzerland ADXN
AegirBio AB Logo AegirBio AB Sweden AEGIR
AGRONOMICS LIMITED Logo AGRONOMICS LIMITED Isle of Man ANIC
AIREA PLC Logo AIREA PLC United Kingdom AIEA
Alkaloid AD Logo Alkaloid AD North Macedonia ALK
Alma Yesodot Ltd. Israel KVSR
Amphastar Pharmaceuticals Inc. Logo Amphastar Pharmaceuticals Inc. United States of America AMPH
Ananda Pharma Plc United Kingdom N/A
AnGes, Inc. Logo AnGes, Inc. Japan 4563